Gut Microbes

Article	Citations
Interactions and substrate selectivity within the SctRST complex of the type III secretion system of enteropathogenic Escherichia coli	327
L. rhamnosus CNCM I-3690 survival, adaptation, and small bowel microbiome impact in human	303
Prolonged oral antimicrobial administration prevents doxorubicin-induced loss of active intestinal stem cells	301
Late-onset sepsis treatment in very preterm infants alters longitudinal microbiome trajectory with lower abundance of Bifidobacterium despite probiotic supplementation	244
Opioid-induced dysbiosis of maternal gut microbiota during gestation alters offspring gut microbiota and pain sensitivity	239
The gut-joint axis mediates the TNF-induced RA process and PBMT therapeutic effects through the metabolites of gut microbiota	192
Dietary fiber-based regulation of bile salt hydrolase activity in the gut microbiota and its relevance to human disease	184
Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis	181
Linking serum vitamin D levels with gut microbiota after 1-year lifestyle intervention with Mediterranean diet in patients with obesity and metabolic syndrome: a nested cross-sectional and prospective	165
Modeling spatial interaction networks of the gut microbiota	159
A high fiber diet or supplementation with Lactococcus lactis subspecies cremoris to pregnant mice confers protection against intestinal injury in adult offspring	157
Effect of diet on the evolution of gut commensal bacteria	153
The ladder of regulatory stringency and balance: an application to the US FDA’s regulation of bacterial live therapeutics	152
Antigenic operon fragmentation and diversification mechanism in Bacteroidota impacts gut metagenomics and pathobionts in Crohn's disease microlesions	138
Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity	137
Intestinal bacteria and colorectal cancer: etiology and treatment	132
3'-Sialyllactose and B. infantis synergistically alleviate gut inflammation and barrier dysfunction by enriching cross-feeding bacteria for short-chain fatty acid biosyn	126
Human milk oligosaccharide metabolism and antibiotic resistance in early gut colonizers: insights from bifidobacteria and lactobacilli in the maternal-infant microbiome	125
Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice	122
Escherichia coli triggers α-synuclein pathology in the LRRK2 transgenic mouse model of PD	122
Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment	115
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome	113
Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase	106
Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion	106
Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency	105

Gut microbiota and tuberculosis infection: interaction and therapeutic potential	101
Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation	101
Progress of linking gut microbiota and musculoskeletal health: casualty, mechanisms, and translational values	100
Meta-analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression	100
Metabolic modeling links gut microbiota to metabolic markers of Parkinson’s disease	98
Pasteurized Akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice	94
Exercise improves gut microbial metabolites in an intensity-dependent manner: a pooled analysis of randomized controlled trials	93
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection	93
Akkermansia muciniphila reduces susceptibility to Listeria monocytogenes infection in mice fed a high-fat diet	93
Microbiota during pregnancy and early life: role in maternal−neonatal outcomes based on human evidence	92
Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation	90
Citrobacter rodentium possesses a functional type II secretion system necessary for successful host infection	90
The crystal structure of the toxin EspC from enteropathogenic Escherichia coli reveals the mechanism that governs host cell entry and cytotoxicity	90
Gut microbiota drives structural variation of exogenous probiotics to enhance colonization	90
Gut microbiome diversity, variability, and latent community types compared with shifts in body weight during the freshman year of college in dormitory-housed adolescents	90
The emerging role of the gut microbiota in vaccination responses	90
Gluten-free diet affects fecal small non-coding RNA profiles and microbiome composition in celiac disease supporting a host-gut microbiota crosstalk	89
mbSparse: an autoencoder-based imputation method to address sparsity in microbiome data	88
In vivo systematic analysis of microbiota-prebiotic crosstalk reveals a synbiotic that effectively ameliorates DSS-induced colitis in mice	87
Proton pump inhibitors are not associated with an increased risk of Clostridioides difficile infection: a systematic review and meta-analysis of randomized controlled tr	87
Gut microbiota and radiation-induced injury: mechanistic insights and microbial therapies	86
Comparison of gnotobiotic communities reveals milk-adapted metabolic functions and unexpected amino acid metabolism by the pre-weaning microbiome	86
Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease	86
The regulatory effect of chitooligosaccharides on islet inflammation in T2D individuals after islet cell transplantation: the mechanism behind Candida albicans abundance	85
Dysbiotic but nonpathogenic shift in the fecal mycobiota of patients with rheumatoid arthritis	83
Engineered bacteria as an orally administered anti-viral treatment and immunization system	81
Unraveling multiple sclerosis: a hidden interaction between intestinal microbiota and host lipid metabolism	81
Communication between the gut microbiota and peripheral nervous system in health and chronic disease	81
Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease	81
The intestinal microbiome of inflammatory bowel disease across the pediatric age range	77
High throughput genome scale modeling predicts microbial vitamin requirements contribute to gut microbiome community structure	77
The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential	76
Maternal milk fat globule membrane enriched gut L. murinus and circulating SCFAs to improve placental efficiency and fetal development in intrauterine growth restricted	75
Gut microbiota-mediated conversion of mangiferin to norathyriol alters short chain fatty acid and urate metabolism	74
Therapeutic potential of Clostridium butyricum anticancer effects in colorectal cancer	73
Antidepressant drugs promote the spread of broad-host-range plasmid in mouse and human gut microbiota	73
The microbiota and the host organism switch between cooperation and competition based on dietary iron levels	73
Regulation of flagellar motility and biosynthesis in enterohemorrhagic Escherichia coli O157:H7	72
Acids produced by lactobacilli inhibit the growth of commensal Lachnospiraceae and S24-7 bacteria	72
Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC	72
Mucus-penetrating microbiota drive chronic low-grade intestinal inflammation and metabolic dysregulation	71
MS-20 enhances the gut microbiota-associated antitumor effects of anti-PD1 antibody	70
Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection	69
Next-generation probiotics – do they open new therapeutic strategies for cancer patients?	69
Multi-strain probiotics during pregnancy in women with obesity influence infant gut microbiome development: results from a randomized, double-blind placebo-controlled study	69
Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review	68
Dietary fiber guar gum-induced shift in gut microbiota metabolism and intestinal immune activity enhances susceptibility to colonic inflammation	68
Gut virome profiling identifies an association between temperate phages and colorectal cancer promoted by Helicobacter pylori infection	67
The Fe-S cluster biosynthesis in Enterococcus faecium is essential for anaerobic growth and gastrointestinal colonization	67
Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection	67

Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy	66
Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice	66
Akkermansia in the gastrointestinal tract as a modifier of human health	65
Alterations in mucosa branched N -glycans lead to dysbiosis and downregulation of ILC3: a key driver of intestinal inflammation	65
Long COVID and gut microbiome: insights into pathogenesis and therapeutics	65
Single cell viral tagging of Faecalibacterium prausnitzii reveals rare bacteriophages omitted by other techniques	65
Efficacy of fecal microbiota transplantation in patients with Parkinson’s disease: clinical trial results from a randomized, placebo-controlled design	65
Gut microbe–host interactions in post-COVID syndrome: a debilitating or restorative partnership?	64
Interactions between the gut microbiota and immune cell dynamics: novel insights into the gut-bone axis	64
The transplantation of the gut microbiome of fat-1 mice protects against colonic mucus layer disruption and endoplasmic reticulum stress induced by high fat diet	64
Metagenomic analysis reveals distinct patterns of gut microbiota features with diversified functions in C. difficile infection (CDI), asymptomatic carriage and non-CDI d	63
Why are so many enteric pathogen infections asymptomatic? Pathogen and gut microbiome characteristics associated with diarrhea symptoms and carriage of diarrheagenic E. coli	62
Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights	62
Quorum sensing modulates bacterial virulence and colonization dynamics of the gastrointestinal pathogen Citrobacter rodentium	62
CobB-mediated deacetylation of the chaperone CesA regulates Escherichia coli O157:H7 virulence	61
Proteome profiling indicates a link between mitochondrial pathways and the host-microbial sensor ELMO1 following Salmonella infection	61
Entamoeba muris mitigates metabolic consequences of high-fat diet in mice	61
Gut metagenomic characteristics of ADHD reveal low Bacteroides ovatus -associated host cognitive impairment	61
CRIg+ macrophages deficiency enhanced inflammation damage in IBD due to gut extracellular vesicles containing microbial DNA	60
Akkermansia muciniphila upregulates genes involved in maintaining the intestinal barrier function via ADP-heptose-dependent activation of the ALPK1/TIFA pathway	60
Clostridioides difficile binary toxin CDT induces biofilm-like persisting microcolonies	60
Sex-specific post-inflammatory dysbiosis mediates chronic visceral pain in colitis	60
Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease	59
Integrative analysis with microbial modelling and machine learning uncovers potential alleviators for ulcerative colitis	59
A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bi	59
The multifaceted virulence of adherent-invasive Escherichia coli	58
Gut microbiota-mediated C-sulfonate metabolism impairs the bioavailability and anti-cholestatic efficacy of andrographolide	58
Resveratrol amplifies the anti-tumor effect of α-PD-1 by altering the intestinal microbiome and PGD2 content	58
Bacillus coagulans ameliorates inflammatory bone loss in post-menopausal osteoporosis via modulating the “Gut-Immune-Bone” axis	57
Fungal feelings in the irritable bowel syndrome: the intestinal mycobiome and abdominal pain	57
Intratumoral microbiome is associated with gastric cancer prognosis and therapy efficacy	57
Secretory IgA dysfunction underlies poor prognosis in Fusobacterium -infected colorectal cancer	57
The human gut microbiome and aging	57
Human gut-associated Bifidobacterium species salvage exogenous indole, a uremic toxin precursor, to synthesize indole-3-lactic acid via tryptophan	57
Fecal microbiota transplantation in hematopoietic cell transplant and cellular therapy recipients: lessons learned and the path forward	56
Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion	56
Role of gut microbes in acute lung injury/acute respiratory distress syndrome	55
The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation	55
Antibiotic-induced gut dysbiosis elicits gut-brain axis relevant multi-omic signatures and behavioral and neuroendocrine changes in a nonhuman primate model	55
Intestinal deguelin drives resistance to acetaminophen-induced hepatotoxicity in female mice	55
Epidemiology of bacterial biofilms on polyps and normal tissues in a screening colonoscopy cohort	55
Comprehensive assessment of machine learning methods for diagnosing gastrointestinal diseases through whole metagenome sequencing data	55
Multi-omics analysis revealing the interplay between gut microbiome and the host following opioid use	54
Gut microbial metabolites of amino acids in liver diseases	54
Gut microbiome at the crossroad of genetic variants and behavior disorders	53
PUFAs add fuel to Crohn’s disease-associated AIEC-induced enteritis by exacerbating intestinal epithelial lipid peroxidation	53
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes	53
Probiotic-induced enrichment of Adlercreutzia equolifaciens increases gut microbiome wellness index and maps to lower host blood glucose levels	52
Long-term yogurt intake and colorectal cancer incidence subclassified by Bifidobacterium abundance in tumor	52
Atovaquone-proguanil and reduced digestive cancer risk: a Toxoplasma gondii connection	52
From a hunger-regulating hormone to an antimicrobial peptide: gastrointestinal derived circulating endocrine hormone-peptide YY exerts exocrine antimicrobial effects against selective gut microbiota	52
Salmonella utilizes L-arabinose to silence virulence gene expression for accelerated pathogen growth within the host	51
Stool multi-omics for the study of host–microbe interactions in inflammatory bowel disease	51
Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney disease	51
Enterohemorrhagic Escherichia coli responds to gut microbiota metabolites by altering metabolism and activating stress responses	51
Lactic acid bacteria and bifidobacteria deliberately introduced into the agro-food chain do not significantly increase the antimicrobial resistance gene pool	51
Pro-mutagenic effects of the gut microbiota in a Lynch syndrome mouse model	51
Membrane protective role of autophagic machinery during infection of epithelial cells by Candida albicans	50
Staphylococcus haemolyticus is a reservoir of antibiotic resistance genes in the preterm infant gut	50
The duodenal mucosa associated microbiome, visceral sensory function, immune activation and psychological comorbidities in functional gastrointestinal disorders with and without self-reported non-celi	50
Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms	50
Systemic exposure to bacterial amyloid curli alters the gut mucosal immune response and the microbiome, exacerbating Salmonella -induced arthritis	50
Stevioside mitigates metabolic dysregulation in offspring induced by maternal high-fat diet: the role of gut microbiota-driven thermogenesis	50
Infant gut microbiota restoration: state of the art	49
The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC	49
Stability in fecal metabolites amid a diverse gut microbiome composition: a one-month longitudinal study of variability in healthy individuals	49
Fusobacterium nucleatum -driven CX3CR1 + PD-L1 + phagocytes route to tumor tissues and reshape tumor microenvir	49
Genome-wide multi-omics analysis reveals the nutrient-dependent metabolic features of mucin-degrading gut bacteria	49
Predicting butyrate- and propionate-forming bacteria of gut microbiota from sequencing data	49
Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases	48
Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands	48
PMA1-containing extracellular vesicles of Candida albicans triggers immune responses and colitis progression	48
Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma	48
Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota	48
A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma	47
Microbiome’s role in musculoskeletal health through the gut-bone axis insights	47
Human milk oligosaccharides combine with Bifidobacterium longum to form the “golden shield” of the infant intestine: metabolic strategies, health effects, and mechanisms	47
Exploring substrate–microbe interactions: a metabiotic approach toward developing targeted synbiotic compositions	46
Gut microbiota alterations induced by Roux-en-Y gastric bypass result in glucose-lowering by enhancing intestinal glucose excretion	46
The interplay between PCOS pathology and diet on gut microbiota in a mouse model	45

Single-cell microbiota phenotyping reveals distinct disease and therapy-associated signatures in Crohn’s disease	45
High variation across E. coli hybrid isolates identified in metabolism-related biological pathways co-expressed with virulent genes	45
Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunity	45
Transfer of microbiota from lean donors in combination with prebiotics prevents excessive weight gain and improves gut-brain vagal signaling in obese rats	45
End-to-end donor screening and manufacturing controls: complementary quality-based strategies to minimize patient risk for donor-derived microbiome therapeutics	45
Magnetic chitin beads (MCB) coated with Vibrio cholerae reveals transcriptome dynamics in adult mice with a complex gut microbiota	45
Akkermansia muciniphila : a deworming partner independent of type 2 immunity	44
Exploring the etiology of colitis: insights from gut microbiota research	44
Alterations in gut virome are associated with cognitive function and minimal hepatic encephalopathy cross-sectionally and longitudinally in cirrhosis	43
Mouse strain-specific responses along the gut-brain axis upon fecal microbiota transplantation from children with autism	43
Fabry disease – a multisystemic disease with gastrointestinal manifestations	43
Sweet, bloody consumption – what we eat and how it affects vascular ageing, the BBB and kidney health in CKD	43
Impact of intensive lifestyle intervention on gut microbiota composition in type 2 diabetes: a post-hoc analysis of a randomized clinical trial	43
Interaction of the Gut-Liver-Brain Axis and the sterolbiome with sexual dysfunction in patients with cirrhosis	43
Paclitaxel chemotherapy disrupts microbiota-enterohepatic bile acid metabolism in mice	43
Using a human colonoid-derived monolayer to study bacteriophage translocation	43
Evaluation of gut microbiota predictive potential associated with phenotypic characteristics to identify multifactorial diseases	43
Integrated analysis of gut metabolome, microbiome, and brain function reveal the role of gut-brain axis in longevity	42
Microbiota and mucosal gene expression of fecal microbiota transplantation or placebo treated patients with chronic pouchitis	42
IgA-mediated control of host-microbial interaction during weaning reaction influences gut inflammation	42
Rotavirus rewires host cell metabolic pathways toward glutamine catabolism for effective virus infection	41
Oral pathobiont Klebsiella chaperon usher pili provide site-specific adaptation for the inflamed gut mucosa	41
The Helicobacter pylori cag pathogenicity island as a determinant of gastric cancer risk	41
Gut bacterial aromatic amine production: aromatic amino acid decarboxylase and its effects on peripheral serotonin production	41
The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention	41
Parvimonas micra , an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes	41
Gut microbiota-driven metabolic alterations reveal gut–brain communication in Alzheimer’s disease model mice	41
Quinic acid alleviates high-fat diet-induced neuroinflammation by inhibiting DR3/IKK/NF-κB signaling via gut microbial tryptophan metabolites	41
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response	41
Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis	41
Dietary iron modulates gut microbiota and induces SLPI secretion to promote colorectal tumorigenesis	41
Viral metagenomics of the gut virome of diarrheal children with Rotavirus A infection	40
Prevotella copri exhausts intrinsic indole-3-pyruvic acid in the host to promote breast cancer progression: inactivation of AMPK via UHRF1-mediated negative regulation	40
Effect of fecal microbiota transplantation on gut microbiota functional profile in recipients of allogeneic hematopoietic cell transplantation	40
Fucose promotes intestinal stem cell-mediated intestinal epithelial development through promoting Akkermansia -related propanoate metabolism	40
The role and mechanism of gut-lung axis mediated bidirectional communication in the occurrence and development of chronic obstructive pulmonary disease	40
A Mediterranean-like fat blend protects against the development of severe colitis in the mucin-2 deficient murine model	40
Lactic acid bacteria derived extracellular vesicles: emerging bioactive nanoparticles in modulating host health	40
ZntA maintains zinc and cadmium homeostasis and promotes oxidative stress resistance and virulence in Vibrio parahaemolyticus	40
Effects of postbiotics on chronic diarrhea in young adults: a randomized, double-blind, placebo-controlled crossover trial assessing clinical symptoms, gut microbiota, and metabolite profiles	40
Maternal-infant probiotic transmission mitigates early-life stress-induced autism in mice	39
Gut microbiota-derived 4-hydroxyphenylacetic acid from resveratrol supplementation prevents obesity through SIRT1 signaling activation	39
M28 family peptidase derived from Peribacillus frigoritolerans initiates trained immunity to prevent MRSA via the complosome-phosphatidylcholine axis	39
Symbiotic biofilms formed by Clostridioides difficile and bacteroides thetaiotaomicron in the presence of vancomycin	39
Gut microbiome in healthy aging versus those associated with frailty	39
Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn’s disease	39
Diet standardization reduces intra-individual microbiome variation	39
Dietary S. maltophilia induces supersized lipid droplets by enhancing lipogenesis and ER-LD contacts in C. elegans	39
Human microbiota influence the immune cell composition and gene expression in the tumor environment of a murine model of glioma	39
Morphine mediated neutrophil infiltration in intestinal tissue play essential role in histological damage and microbial dysbiosis	39
Unveiling the hidden players: exploring the role of gut mycobiome in cancer development and treatment dynamics	38
Psyllium fiber protects mice against western diet-induced metabolic syndrome via the gut microbiota-dependent mechanism	38
Neonatal necrotizing enterocolitis: Clostridium butyricum and Clostridium neonatale fermentation metabolism and enteropathogenicity	38
The hidden base of the iceberg: gut peptidoglycome dynamics is foundational to its influence on the host	38
Dietary fiber for the prevention of childhood obesity: a focus on the involvement of the gut microbiota	38
Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project	38
Long- and short-term effects of fecal microbiota transplantation on antibiotic resistance genes: results from a randomized placebo-controlled trial	38
Metaproteomics reveals age-specific alterations of gut microbiome in hamsters with SARS-CoV-2 infection	37
Primers matter: Influence of the primer selection on human fungal detection using high throughput sequencing	37
Actively replicating gut bacteria identified by 5-ethynyl-2’-deoxyuridine (EdU) click chemistry and cell sorting	37
Reexamining the role of Fusobacterium nucleatum subspecies in clinical and experimental studies	37
Gut microbiome responds to alteration in female sex hormone status and exacerbates metabolic dysfunction	36
Commensal microbiota-derived metabolite agmatine triggers inflammation to promote colorectal tumorigenesis	36
The microbiota-derived bile acid taurodeoxycholic acid improves hepatic cholesterol levels in mice with cancer cachexia	36
Spatio-temporal dynamics of the human small intestinal microbiome and its response to a synbiotic	36
Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst’s FDA approval and implications	36
DSS treatment does not affect murine colonic microbiota in absence of the host	36
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis	36
Interleukin-1β secretion induced by mucosa-associated gut commensal bacteria promotes intestinal barrier repair	36
Breastfeeding and the major fermentation metabolite lactate determine occurrence of Peptostreptococcaceae in infant feces	35
Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions	35
Comparing early life nutritional sources and human milk feeding practices: personalized and dynamic nutrition supports infant gut microbiome development and immune system maturation	35
Diet-induced shifts in the gut microbiota influence anastomotic healing in a murine model of colonic surgery	35
Bacteroides fragilis alleviates necrotizing enterocolitis through restoring bile acid metabolism balance using bile salt hydrolase and inhibiting FXR-NLRP3 signaling pathway	35
B. longum CKD1 enhances the efficacy of anti-diabetic medicines through upregulation of IL- 22 response in type 2 diabetic mice	35
Fecal microbiota transplantation derived from mild cognitive impairment individuals impairs cerebral glucose uptake and cognitive function in wild-type mice: Bacteroidetes	35
Better together– Salmonella biofilm-associated antibiotic resistance	35
The transcriptional regulation of the horizontally acquired iron uptake system, yersiniabactin and its contribution to oxidative stress tolerance and pathogenicity of globally emerging	35
Alcaligenes faecalis promotes colitis to colorectal cancer transition through IgA+ B cell suppression and vinculin acetylation	35
The landscape in the gut microbiome of long-lived families reveals new insights on longevity and aging – relevant neural and immune function	35
Lactobacillus rhamnosus GG ameliorates osteoporosis in ovariectomized rats by regulating the Th17/Treg balance and gut microbiota structure	35
Metagenomic source tracking after microbiota transplant therapy	34
Preterm infants at low risk for early-onset sepsis differ in early fecal microbiome assembly	34
A dietary carbohydrate – gut Parasutterella – human fatty acid biosynthesis metabolic axis in obesity and type 2 diabetes	34
Abnormalities in gut virome signatures linked with cognitive impairment in older adults	34
Methodological challenges in neonatal microbiome research	34
Diverse but desolate landscape of gut microbial azoreductases: A rationale for idiopathic IBD drug response	34
Fusobacterium nucleatum promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1/TIFA axis activation	34
Myeloid-derived suppressor cells prevent disruption of the gut barrier, preserve microbiota composition, and potentiate immunoregulatory pathways in a rat model of experimental autoimmune encephalomye	34
Microbial bile salt hydrolase activity influences gene expression profiles and gastrointestinal maturation in infant mice	34
Intestinal flora: a potential pathogenesis mechanism and treatment strategy for type 1 diabetes mellitus	34
Hydrogen peroxide in breast milk is crucial for gut microbiota formation and myelin development in neonatal mice	33
The influence of the gut microbiome on ovarian aging	33
The development of live biotherapeutics against Clostridioides difficile infection towards reconstituting gut microbiota	33
How longitudinal data can contribute to our understanding of host genetic effects on the gut microbiome	33